Netarsudil-associated conjunctival pigmentation
Open Access
- 27 March 2025
- journal article
- case report
- Published by Elsevier in American Journal of Ophthalmology Case Reports
- Vol. 38, 102311
Abstract
No abstract availableKeywords
Funding Information
- Research to Prevent Blindness
This publication has 19 references indexed in Scilit:
- Crystalline keratopathy following long-term netarsudil therapyAmerican Journal of Ophthalmology Case Reports, 2024
- Status of Rho kinase inhibitors in glaucoma therapeutics—an overviewInternational Ophthalmology, 2021
- Netarsudil-associated epithelial keratopathyAmerican Journal of Ophthalmology Case Reports, 2020
- Reticular Bullous Epithelial Edema in Corneas Treated with Netarsudil: A Case SeriesAmerican Journal of Ophthalmology, 2020
- Discovery and Preclinical Development of Netarsudil, a Novel Ocular Hypotensive Agent for the Treatment of GlaucomaJournal of Ocular Pharmacology and Therapeutics, 2018
- Two Phase 3 Clinical Trials Comparing the Safety and Efficacy of Netarsudil to Timolol in Patients With Elevated Intraocular Pressure: Rho Kinase Elevated IOP Treatment Trial 1 and 2 (ROCKET-1 and ROCKET-2)American Journal of Ophthalmology, 2018
- Double-masked, Randomized, Dose–Response Study of AR-13324 versus Latanoprost in Patients with Elevated Intraocular PressureOphthalmology, 2015
- Side Effects Associated with Prostaglandin Analog TherapySurvey of Ophthalmology, 2008
- Tumors of the conjunctiva and corneaSurvey of Ophthalmology, 2004
- Conjunctival Melanosis and MelanomaOphthalmology, 1984